• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 15 Page 1 of 1
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  1069
Corn protein Pending
  1062
Saccharomyces cerevisiae strain OYR-185 Apr 5, 2023 FDA has no questions (in PDF) (214 kB)
  693
D-psicose Aug 28, 2017 FDA has no questions (in PDF) (97 kB)
  301
Siraitia grosvenorii Swingle (Luo Han Guo) fruit extract (SGFE) Jan 15, 2010 FDA has no questions Apr 8, 2011
  300
Trisodium diphosphate Dec 16, 2009 FDA has no questions
  299
Lycopene from Escherichia coli expressing lycopene biosynthetic enzymes Sep 22, 2009 At the notifier's request, FDA ceased to evaluate this notice
  298
Silicon dioxide Oct 9, 2009 At the notifier's request, FDA ceased to evaluate this notice
  321
  297
Erythritol fatty acid esters
   (Resubmission of GRN 203)
Dec 15, 2009 FDA has no questions
  296
Lipase enzyme preparation from a genetically modified strain of Aspergillus niger Oct 1, 2009 FDA has no questions
  295
Aqueous extract of Emblica officinalis Nov 23, 2009 At the notifier's request, FDA ceased to evaluate this notice
  322
  294
Haematococcus pluvialis extract containing astaxanthin esters Jan 6, 2010 FDA has no questions; some uses may require a color additive listing
  293
Glutathione
   (Resubmission of GRN 244)
Dec 22, 2009 FDA has no questions
  292
Cellulase enzyme preparation derived from a genetically modified strain of Myceliophthora thermophila Sep 29, 2009 FDA has no questions
  291
Crystalline lutein Nov 6, 2009 FDA has no questions; some uses may require a color additive listing
  201
Asparaginase enzyme preparation from Aspergillus oryzae expressing the asparaginase gene from A. oryzae Nov 24, 2006 FDA has no questions

GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-